Researchers at Brigham and Women's Hospital have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer.
Jun 14, 2024
0
49
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy—a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable ...
Jun 12, 2024
0
14
Cancer is one of the most devastating diagnoses that a person can receive, and it is a society-wide problem. According to the National Cancer Institute, an estimated 2,001,140 new cases of cancer will be diagnosed in the ...
Jun 7, 2024
0
29
A bioengineering breakthrough which helps repair damaged bones without causing the negative side effects of other treatments could lead to better results for patients, scientists say.
Jun 7, 2024
0
15
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and is projected to become the second-leading cause of cancer-related death by 2030. Although progress has been made in improving outcomes, ...
May 28, 2024
0
17
When you disable the brakes on a race car, it quickly crashes. Dr. Barak Rotblat wants to do something similar to brain cancer cells. He wants to disable their ability to survive glucose starvation. In fact, he wants to speed ...
May 20, 2024
0
31
A new editorial paper was published in Oncoscience on May 6, 2024, titled, "Restoring our ubiquitination machinery to overcome resistance in cancer therapy."
Jun 10, 2024
0
0
In the relentless fight against cancer, a new technology promises to shed light on how we track and understand the spread of this disease within the body. A research team from Northeastern University and Dartmouth College ...
Jun 7, 2024
0
1
The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.
Jun 3, 2024
0
0
A new editorial paper was published in Oncoscience, titled "PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs."
May 24, 2024
0
0
